Home Medusas petrifying gaze: Severe, diffused and refractory calcinosis from a patient with ACA-negative CREST syndrome
Article Open Access

Medusas petrifying gaze: Severe, diffused and refractory calcinosis from a patient with ACA-negative CREST syndrome

  • Lili Xu , Jie Wu , Shu Liang , Yilin Lu , Yilu Qin , Chao Zhang , Miaomiao Ma and Wenqiang Fan ORCID logo EMAIL logo
Published/Copyright: July 1, 2025
Become an author with De Gruyter Brill

A 62-year-old female with a decade-long history of Raynaud phenomenon (Figure 1A) developed xerostomia, esophageal dysmotility, and dysphagia, accompanied by severe disseminated subcutaneous calcifications predominantly affecting the hips and lower extremities (Figure 1B). Muscle strength remained normal (5/5) in all extremities. Laboratory examination revealed an elevated erythrocyte sedimentation rate (ESR) of 47 mm/h and a positive cytoplasmic-granular-pattern antinuclear antibody with a titer of 1∶80. Anti-centromere antibodies (ACA) were negative, and serum creatine kinase levels were within the normal range. Chest computed tomography (CT) showed interstitial lung disease (ILD). Radiographs of the right elbow, pelvis, and right femur demonstrated patchy soft tissue calcifications resembling gypsum (Figure 1C, 1D). Studies show that the sensitivity of ACA in diagnosing CREST syndrome is 65%, with a specificity of 99.9%.[1] Consequently, a negative ACA alone cannot exclude the diagnosis, and clinical features along with other diagnostic findings remain crucial. Based on the available evidence, she was diagnosed with CREST syndrome complicated by ILD. The patient was treated with prednisone, cyclophosphamide, and hydroxychloroquine sulfate. Within two weeks, her Raynaud phenomenon and xerostomia improved, with ESR returning to normal. Three months later, the subcutaneous nodules had shrunk.

Figure 1 Clinical manifestations and imaging findings. A. Raynaud phenomenon. B. Multiple subcutaneous firm nodules on the extremities, which had ulcerated and released white, calcium-like material. C & D. X-rays of the upper extremities, pelvis, and femur showing multiple patchy calcifications in the pelvis, femur, and adjacent soft tissues.
Figure 1

Clinical manifestations and imaging findings. A. Raynaud phenomenon. B. Multiple subcutaneous firm nodules on the extremities, which had ulcerated and released white, calcium-like material. C & D. X-rays of the upper extremities, pelvis, and femur showing multiple patchy calcifications in the pelvis, femur, and adjacent soft tissues.

Calcinosis cutis refers to the deposition of insoluble calcium salts in the skin and subcutaneous tissues, typically in the form of dystrophic calcification and consisting primarily of hydroxyapatite crystals that resemble bone.[2] The pathogenesis is poorly understood but vascular ischemia and repeated microtraumas are thought to be the key factors driving its development. It is commonly observed in conditions such as systemic sclerosis (SSc), systemic lupus erythematosus, and dermatomyositis. Calcinosis represents a great burden for SSc patients due to skin ulceration, infection, fistulation, and consequent disability, which significantly impairs patients’ quality of life. The most frequently affected areas are the hands and wrists, where calcinosis can lead to pain, limited joint mobility, ulceration, and secondary infections.[3] In this case, the patient exhibited extensive and severe subcutaneous calcinosis, reminiscent of Medusa’s petrifying gaze, where calcification progressively spread from the skin into deeper tissues, severely restricting joint mobility.


Address for correspondence: *Wenqiang Fan, Xinxiang Central Hospital, The Fourth Clinical College of Xinxiang Medical University, No. 56, Jin Sui Avenue, Weibin District, Xinxiang City, Henan Province, China.

Acknowledgements

We extend our sincere gratitude to the patient, medical practitioners and scholars who participated in this research study.

  1. Author contributions

    LLX wrote the first version of the paper. JW, YLL, YLQ and WQF proofread the paper before submission. CZ and MMM edited and organized the images. SL evaluated the patient, set up treatment and follow-up. All eight authors approved the final version to be published.

  2. Source of funding

    None.

  3. Ethical approval

    Ethical approval was obtained from the institutional ethical committee, Number: 2022-150.

  4. Informed consent

    Informed consent has been obtained. The patient has given the consent for his images and other clinical information to be reported in the journal.

  5. Conflict of interest

    All authors declare no conflict of interest.

  6. Use of large language models, AI and machine learning tools

    This article did not use large language models, AI, or machine learning tools.

  7. Data availability statement

    The data are not publicly available due to privacy or ethical restrictions. The data that support the findings of this study are available on request from the corresponding author.

References

[1] Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003;5:80–93.10.1186/ar628Search in Google Scholar PubMed PubMed Central

[2] Hsu VM, Emge T, Schlesinger N. X-ray diffraction analysis of spontaneously draining calcinosis in scleroderma patients. Scand J Rheumatol. 2017;46:118–121.10.1080/03009742.2016.1219766Search in Google Scholar PubMed

[3] Davuluri S, Lood C, Chung L. Calcinosis in systemic sclerosis. Curr Opin Rheumatol. 2024;36:360–369.10.1097/BOR.0000000000000900Search in Google Scholar PubMed

Received: 2025-02-12
Accepted: 2025-04-01
Published Online: 2025-07-01

© 2025 Lili Xu, Jie Wu, Shu Liang, Yilin Lu, Yilu Qin, Chao Zhang, Miaomiao Ma, Wenqiang Fan, published by De Gruyter on behalf of NCRC-DID

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 1.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/rir-2025-0015/html
Scroll to top button